5."It felt like an extremely well-rounded profession. You get to do inpatient and outpatient. You get to do office procedures ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Baystreet.ca News Commentary – Innovation in biotech is rapidly reshaping how we fight cancer, a trend reflected in the ...

Ovarian cancer, often termed a silent killer, remains underdiagnosed due to vague symptoms and lack of screening. With high ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

Our recent webinar series, ‘Unlocking Precision Oncology’s Full Potential through Next-Gen Molecular Analysis’, showcased ...

New research suggests that a ctDNA assay can detect colorectal cancer recurrence months before it is detected via imaging.

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...

During a live event, Ahmad Tarhini, MD, PhD, discussed the RELATIVITY-047 trial of nivolumab/relatlimab vs nivolumab alone in ...

Venoarterial Extracorporeal membrane oxygenation (VA ECMO) for extracorporeal cardiopulmonary resuscitation (ECPR) in adults in refractory cardiac arrest Interventional procedure consultation ...